3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 31.78
+0.98 (3.18%)
Nov 3, 2025, 4:08 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 73.68 billion as of November 3, 2025. Its market cap has increased by 368.32% in one year.
Market Cap
73.68B
Enterprise Value
71.53B
Revenue
9.94B
Ranking
n/a
PE Ratio
29.31
Stock Price
31.78
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 73.68B, an increase of 225.04%. That is a compound annual growth rate of 12.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 73.68B | 414.54% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | 17.98B | -29.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 265.66B |
| Hansoh Pharmaceutical Group Company | 215.76B |
| JD Health International | 194.33B |
| Innovent Biologics | 149.08B |
| WuXi Biologics | 147.15B |
| Sino Biopharmaceutical | 126.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.47B |
| Akeso | 104.46B |